+ Follow PERINDOPRIL AND INDAPAMIDE Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 167114
[Title] => BP drug launched
[Summary] => The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on.
A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept, was formally launched at the recent annual convention of the Philippine Heart Association (PHA) at the EDSA Shangri-La Hotel.
The symposium, organized in cooperation with leading pharmaceutical company Servier Phils., featured two internationally renowned speakers, both experts in the fields of high blood pressure and heart disease.
[DatePublished] => 2002-07-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 167165
[Title] => BP drug launched
[Summary] => The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on.
A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept, was formally launched at the recent annual convention of the Philippine Heart Association (PHA) at the EDSA Shangri-La Hotel.
The symposium, organized in cooperation with leading pharmaceutical company Servier Phils., featured two internationally renowned speakers, both experts in the fields of high blood pressure and heart disease.
[DatePublished] => 2002-07-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
PERINDOPRIL AND INDAPAMIDE
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 167114
[Title] => BP drug launched
[Summary] => The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on.
A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept, was formally launched at the recent annual convention of the Philippine Heart Association (PHA) at the EDSA Shangri-La Hotel.
The symposium, organized in cooperation with leading pharmaceutical company Servier Phils., featured two internationally renowned speakers, both experts in the fields of high blood pressure and heart disease.
[DatePublished] => 2002-07-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 167165
[Title] => BP drug launched
[Summary] => The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on.
A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept, was formally launched at the recent annual convention of the Philippine Heart Association (PHA) at the EDSA Shangri-La Hotel.
The symposium, organized in cooperation with leading pharmaceutical company Servier Phils., featured two internationally renowned speakers, both experts in the fields of high blood pressure and heart disease.
[DatePublished] => 2002-07-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
